Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Breast Neoplasms × adavosertib × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 2 Solid Tumors 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Triple-negative Metastatic Breast Cancer 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdomyosarcoma 1 Previously Treated Non Small Cell Lung Cancer 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Pinealoma 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Metastatic Pancreatic Adenocarcinoma 1 Meningeal Carcinomatosis 1 Medulloblastoma 1 Lymphoid Interstitial Pneumonia 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1

Interventions

Trastuzumab 241 Paclitaxel 192 Cyclophosphamide 158 Docetaxel 134 Letrozole 113 Capecitabine 113 Fulvestrant 106 Doxorubicin 103 Bevacizumab 87 Carboplatin 81 exemestane 80 Anastrozole 79 Lapatinib 70 Tamoxifen 69 Albumin-Bound Paclitaxel 57 palbociclib 54 pertuzumab 52 Taxes 51 Gemcitabine 50 Radiotherapy 44 eribulin 43 Everolimus 41 pembrolizumab 40 Ado-Trastuzumab Emtansine 40 Vinorelbine 38 130-nm albumin-bound paclitaxel 35 ixabepilone 32 Epirubicin 28 pegfilgrastim 25 liposomal doxorubicin 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡